'Efficacy' diaporamas de présentation

The Gastrointestinal System: Digestive Disorders

1.63k views • 100 slides

The Modern Approach to Infection Control

WHO Webinar series, 16 February 2010. The Modern Approach to Infection Control. Professor Didier Pittet, MD, MS, Infection Control Program University of Geneva Hospitals, Switzerland Division of Investigative Science Imperial College, London, UK Lead, 1st Global Patient Safety Challenge,

1.45k views • 88 slides

NICOTINE REPLACEMENT THERAPY IN SMOKING CESSATION

NICOTINE REPLACEMENT THERAPY IN SMOKING CESSATION. SCOTT SLEDGE, MD FEBRUARY 2, 1999. CIGARETTE SMOKING RELATED MORTALITY. Cigarette Smoking is the single most preventable cause of premature death in the United States. >400,000 deaths in the U.S. / year

995 views • 64 slides

1.29k views • 57 slides

Influenza Vaccine Effectiveness: Considerations for Prioritization of Pandemic Influenza Vaccine

Influenza Vaccine Effectiveness: Considerations for Prioritization of Pandemic Influenza Vaccine Carolyn B. Bridges, MD National immunization Program, CDC for NVAC/ACIP Influenza Vaccine Working Group April 20, 2005 Influenza Vaccine Effectiveness (VE)

1.4k views • 37 slides

Oral anticoagulant therapy : a look to the future

Oral anticoagulant therapy : a look to the future. Alexander G. G. Turpie Department of Medicine HHS-General Hospital Hamilton, Canada . Antithrombotics That Have Changed Clinical Practice. Anticoagulants Low-molecular-weight heparin Antiplatelet Drugs Thienopyridines

1.08k views • 35 slides

Hygiene II

669 views • 35 slides

PK and PD Studies for Systemic Exposure of Locally Acting Drugs Industry View

PK and PD Studies for Systemic Exposure of Locally Acting Drugs Industry View. Lester I. Harrison, PhD Division Scientist 3m Pharmaceuticals. Value of OINDP PK. Systemic Absorption = Systemic Exposure Measure of systemic safety for locally acting drugs PK is an Established BE Metric

790 views • 34 slides

Dietary Supplements: Kava: a case study

Dietary Supplements: Kava: a case study. NUTR 547 - Nutrition Update David L. Gee, PhD Summer 2006. Learning Objectives. Identify health claims associated with kava use. Define generalized anxiety disorder and describe its prevalence. Describe the biology and therapeutic control of anxiety.

744 views • 31 slides

528 views • 31 slides

National Program 308 Assessment and Customer Workshop Feb 28 - Mar 2, 2006 Jim Bair, vice president North American Mille

412 views • 31 slides

Motivation and Emotion in Daily Life

Motivation and Emotion in Daily Life. Personal Control Beliefs March 18 th , 2019 Erik Chevrier. Check In. How is everything going? What is going well? What could be improved on? Is this class meeting your expectations? Why? Why not? Are you enjoying the material?

406 views • 27 slides

Years of Clinical Experience

698 views • 25 slides

Prophylaxis of invasive fungal infections in high risk patients with hematologic malignancies

Antifungal Prophylaxis. Prophylaxis of invasive fungal infections in high risk patients with hematologic malignancies. Olaf Penack . Background . Incidence IFI in neutropenia 3% - 40% High mortality rates Prophylaxis in allogeneic HSCT/BMT !

704 views • 23 slides

Disclosures

Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors During Elective Coronary Revascularization A meta-analysis of randomized trials performed in the era of stents and thienopyridines Winchester DE, Wen X, Brearley WD, Park KE, Anderson RD, Bavry AA . Disclosures.

299 views • 15 slides

Integration of Spray Quality Information

Integration of Spray Quality Information. by Tim Stuenkel Applications Engineer,. Why Measure Drop Size?. Drift vs. Efficacy Pesticide labeling regulations Provide basic spray quality information to the end user . Drop Size Measurements. Reference tips are acquired and tested

259 views • 14 slides

Motivation

Motivation. Learning Something New. Think back to when you began learning a new skill or sport technique. What was the most unmotivating information or comment you experienced? What affect did it have on you? Were you ready to give up? What kept you going?. Motivation & Learning.

242 views • 10 slides

Theory of Change

Theory of Change. Based on the Works of Thomas D. Morton. 5 variables that influence change:. efficacy. present discomfort. preferred alternative future. emotional security. internalization of responsibility. Present Discomfort. You must have a need for something to be different.

288 views • 8 slides

B. Winblad and N. Poritis International Journal of Geriatric Psychiatry 1999, 14: 135-146

Memantine in Severe Dementia: Results of the M-Best Study Benefit and Efficacy in Severely Demented Patients During Treatment With Memantine. B. Winblad and N. Poritis International Journal of Geriatric Psychiatry 1999, 14: 135-146 . Study Design. No. of patients N = 166 (nursing home)

264 views • 4 slides

BACKGROUND AND OBJECTIVES

269 views • 1 slides